KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Repligen (RGEN) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Repligen (RGEN) over the last 16 years, with Q3 2025 value amounting to $748.7 million.

  • Repligen's Cash & Equivalents fell 449.22% to $748.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $748.7 million, marking a year-over-year decrease of 449.22%. This contributed to the annual value of $757.6 million for FY2024, which is 84.1% up from last year.
  • As of Q3 2025, Repligen's Cash & Equivalents stood at $748.7 million, which was down 449.22% from $708.9 million recorded in Q2 2025.
  • In the past 5 years, Repligen's Cash & Equivalents registered a high of $809.1 million during Q2 2024, and its lowest value of $516.6 million during Q1 2023.
  • For the 5-year period, Repligen's Cash & Equivalents averaged around $670.4 million, with its median value being $697.2 million (2025).
  • As far as peak fluctuations go, Repligen's Cash & Equivalents tumbled by 1876.75% in 2022, and later skyrocketed by 5110.4% in 2024.
  • Repligen's Cash & Equivalents (Quarter) stood at $603.8 million in 2021, then decreased by 13.31% to $523.5 million in 2022, then soared by 43.53% to $751.3 million in 2023, then increased by 0.84% to $757.6 million in 2024, then dropped by 1.17% to $748.7 million in 2025.
  • Its Cash & Equivalents stands at $748.7 million for Q3 2025, versus $708.9 million for Q2 2025 and $697.2 million for Q1 2025.